← All trials
NCT03775460
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2019
- Primary completion
- Apr 1, 2022
- Completion date
- Apr 1, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 550
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of LondonLead sponsor
- University of LondonOverall official - principal investigator
- Dr. Soetomo General HospitalCollaborator
- Oswaldo Cruz FoundationCollaborator
- The Leprosy Mission Trust India (TLMTI)Collaborator
- The Leprosy Mission NepalCollaborator
- The Leprosy Mission BangladeshCollaborator
- Leprosy Research InitiativeCollaborator
- Bombay Leprosy Project, IndiaCollaborator
- Alert Hospital, EthiopiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.